Bitter, I.
Groc, M.
Delsol, C.
Fabre, C.
Fagard, M.
Barthe, L.
Gaudoux, F.
Brunner, V.
Brackman, F.
Tonner, F.
This article is maintained by: Elsevier
Article Title: Efficacy of F17464, a new preferential D3 antagonist in a placebo-controlled phase 2 study of patients with an acute exacerbation of schizophrenia
Journal Title: European Psychiatry
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eurpsy.2017.02.428
Content Type: simple-article
Copyright: Copyright © 2017 Published by Elsevier Masson SAS